Vivos Therapeutics, Inc. (VVOS) Earnings
|
Expand Research on VVOS
| Next EPS Date | 11/12/26 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -10.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | -$0.31 | -$0.37 | +$0.06 | $5.15M | $5.57M | N/A |  | | Details | |
| 5/18/26 |
Q126 | N/A | -$0.45 | N/A | N/A | $7.5M | N/A | N/A | N/A | ||
| 5/20/26 |
Q126 | -$0.52 | -$0.45 | -$0.07 | $5.14M | $7.5M | N/A | | | Details | |
| 3/30/26 |
Q425 | N/A | -$0.50 | N/A | N/A | $6.3M | N/A | N/A | N/A | ||
| 3/26/26 |
Q425 | N/A | -$0.50 | N/A | N/A | $6.3M | N/A | N/A | N/A | ||
| 11/19/25 |
Q325 | -$0.49 | -$0.48 | -$0.01 | $6.8M | $4.97M | N/A | | | Details | |
| 11/13/25 |
Q325 | N/A | -$0.48 | N/A | N/A | $4.97M | N/A | N/A | N/A | ||
| 11/12/25 |
Q325 | N/A | -$0.48 | N/A | N/A | $4.97M | N/A | N/A | N/A |
